Please note: AABB reserves the right to make updates to this program.
Thursday, April 15, 2021
2:00 - 3:15 PM (ET)
Presented by Cerus Corporation
As the October 2021 deadline approaches to implement the FDA’s bacterial risk mitigation guidance, blood centers and hospitals have been evaluating how to ensure a safe and available platelet supply. In this webinar, two institutions will share their mitigation strategies. Safety considerations will be discussed regarding pathogen reduction and testing, as well as two approaches to maintaining platelet availability, including the use of and clinical assessment of variable dose platelets.
This Science & Innovation Forum is complimentary to all, but registration is required. By registering for this AABB-hosted program you consent to have your information shared with the program sponsor, Cerus Corporation. Register here.
Moderator: Marion Lanteri, PhD, Director of Scientific Affairs, Cerus
Ryan A. Metcalf, MD, CQA(ASQ)
Medical Director, Transfusion Service
Assistant Professor, Inpatient Chief Value Officer, Department of Pathology
University of Utah Health
Tho D. Pham, MD
Clinical Associate Professor, Department of Pathology
Stanford University Chief Medical Officer
Stanford Blood Center
Mrigender Virk, MD
Clinical Assistant Professor of Pathology
Division of Transfusion Medicine Associate Director of Transfusion Medicine Fellowship
Stanford University School of Medicine
The content of this event was developed independently from the AABB continuing education program. The opinions expressed are those of the faculty. Continuing education (CE) or continuing medical education (CME) credit are not offered.